QTL |
GWAS Catalog Study |
Disease Trait |
Study Size |
Risk Allele |
Risk Allele Frequency |
P Value |
P Value MLOG |
Peak Marker |
Reported Odds Ratio or Beta-coefficient |
Ontology Accession |
PubMed |
GWAS552613_H |
GCST90102681 |
1-docosahexaenoyl-GPE (22:6) levels |
8,809 European ancestry individuals |
A |
NR |
2E-20 |
19.699 |
rs7350789 |
0.141 |
1-docosahexaenoyl-GPE (22:6) measurement (EFO:0800296)
|
PMID:35050183 |
GWAS587285_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.64 |
3E-7 |
6.523 |
rs7350789 |
0.085 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
GWAS587286_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
NR |
2E-28 |
27.699 |
rs7350789 |
0.049 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
GWAS587478_H |
GCST007143 |
Total cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.654 |
4E-22 |
21.398 |
rs7350789 |
0.047 |
total cholesterol measurement (EFO:0004574)
|
PMID:29507422 |
GWAS587828_H |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.654 |
4E-13 |
12.398 |
rs7350789 |
0.032 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS587829_H |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.64 |
0.000003 |
5.523 |
rs7350789 |
0.071 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS587832_H |
GCST007142 |
Triglycerides |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
NR |
2E-18 |
17.699 |
rs7350789 |
0.035 |
triglyceride measurement (EFO:0004530)
|
PMID:29507422 |
GWAS601091_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.654 |
6E-100 |
99.222 |
rs7350789 |
0.084 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS601124_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.676 |
1E-7 |
7 |
rs7350789 |
0.071 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS601125_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.64 |
4E-16 |
15.398 |
rs7350789 |
0.113 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS601126_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
0.628 |
0.000004 |
5.398 |
rs7350789 |
0.104 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS601127_H |
GCST007140 |
High density lipoprotein cholesterol levels |
76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals |
G |
NR |
3E-124 |
123.523 |
rs7350789 |
0.085 |
high density lipoprotein cholesterol measurement (EFO:0004612)
|
PMID:29507422 |
GWAS601850_H |
GCST008929 |
Phosphatidylethanolamine levels |
2,045 European ancestry individuals |
A |
NR |
4E-20 |
19.398 |
rs7350789 |
0.2979 |
phosphatidylethanolamine measurement (EFO:0010228)
|
PMID:31551469 |
GWAS601886_H |
GCST006614 |
Total cholesterol levels |
215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals |
A |
0.3451 |
4E-78 |
77.398 |
rs7350789 |
0.0522 |
total cholesterol measurement (EFO:0004574)
|
PMID:30275531 |
GWAS609543_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-11 |
10.699 |
rs7350789 |
0.054938268 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS609544_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-14 |
13.699 |
rs7350789 |
0.0702734 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610017_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-25 |
25 |
rs7350789 |
0.11972121 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610026_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
7E-32 |
31.155 |
rs7350789 |
0.10872544 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610636_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
8E-35 |
34.097 |
rs7350789 |
0.10312867 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610637_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
4E-30 |
29.398 |
rs7350789 |
0.09544789 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610653_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-19 |
18.398 |
rs7350789 |
0.13139343 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610655_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-18 |
17.523 |
rs7350789 |
0.109545276 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS610657_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-10 |
10 |
rs7350789 |
0.09513239 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
None Available |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
2E-11 |
10.699 |
rs7350789 |
0.08209028 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS611423_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-12 |
11.523 |
rs7350789 |
0.08568997 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS611493_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
6E-28 |
27.222 |
rs7350789 |
0.09362299 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS611494_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
1E-27 |
27 |
rs7350789 |
0.08421296 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS617256_H |
GCST90092879 |
Triglycerides to total lipids ratio in large VLDL |
115,071 European ancestry individuals |
G |
0.646053 |
1E-248 |
248 |
rs7350789 |
0.144797 |
triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317)
|
PMID:35213538 |
GWAS617257_H |
GCST90092877 |
Phospholipids to total lipids ratio in large VLDL |
115,071 European ancestry individuals |
G |
0.646053 |
2E-192 |
191.699 |
rs7350789 |
0.124104 |
very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipids:total lipids ratio (EFO:0020946)
|
PMID:35213538 |
GWAS617706_H |
GCST90092873 |
Free cholesterol to total lipids ratio in large VLDL |
115,071 European ancestry individuals |
G |
0.646053 |
5E-99 |
98.302 |
rs7350789 |
0.0904029 |
very low density lipoprotein cholesterol measurement (EFO:0008317) free cholesterol:total lipids ratio (EFO:0020945)
|
PMID:35213538 |
GWAS628936_H |
GCST90002383 |
Hematocrit |
408,112 British individuals |
A |
0.354791 |
1E-13 |
13 |
rs7350789 |
0.017170137 |
hematocrit (EFO:0004348)
|
PMID:32888494 |
GWAS629768_H |
GCST007286 |
Triglycerides x physical activity interaction (2df test) |
7,294 African American inactive individuals, 12,832 African American active individuals, 1,352 Asian ancestry inactive individuals, 3,049 Asian ancestry active individuals, 20,622 European ancestry inactive individuals, 51,480 European ancestry active individuals, 2,166 Hispanic or Latin American inactive individuals, 3,486 Hispanic or Latin American active individuals |
A |
0.346 |
1E-149 |
149 |
rs7350789 |
N/A |
triglyceride measurement (EFO:0004530) physical activity (EFO:0003940)
|
PMID:30670697 |
GWAS629934_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-47 |
47 |
rs7350789 |
0.18179038 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS629942_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
3E-13 |
12.523 |
rs7350789 |
0.09118287 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS629946_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
1E-12 |
12 |
rs7350789 |
0.08727236 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630091_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
5E-11 |
10.302 |
rs7350789 |
0.057159528 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630258_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-85 |
84.699 |
rs7350789 |
0.1738073 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630390_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
2E-10 |
9.699 |
rs7350789 |
0.0665491 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630400_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
4E-7 |
6.398 |
rs7350789 |
0.064160354 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630401_H |
GCST009242 |
Serum metabolite levels |
6,263 Finnish ancestry men |
? |
NR |
5E-7 |
6.302 |
rs7350789 |
0.061311882 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630532_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
8E-10 |
9.097 |
rs7350789 |
0.06674564 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS630533_H |
GCST009240 |
Serum metabolite levels (CMS) |
6,263 Finnish ancestry men |
? |
NR |
9E-10 |
9.046 |
rs7350789 |
0.05438878 |
serum metabolite measurement (EFO:0005653)
|
PMID:31636271 |
GWAS631429_H |
GCST011050 |
Postprandial triglyceride response |
5,630 individuals |
A |
0.36 |
5E-8 |
7.302 |
rs7350789 |
0.11 |
triglyceride measurement (EFO:0004530)
|
PMID:32603185 |
GWAS633159_H |
GCST90277296 |
Phosphatidylcholine (17:0_18:1) levels |
7,073 Finnish ancestry individuals |
A |
0.39282 |
4E-11 |
10.398 |
rs7350789 |
0.112631 |
|
PMID:37907536 |
GWAS633236_H |
GCST90277370 |
Sphingomyelin (d34:1) levels |
7,174 Finnish ancestry individuals |
A |
0.39282 |
7E-11 |
10.155 |
rs7350789 |
0.110435 |
|
PMID:37907536 |
GWAS745956_H |
GCST90269690 |
Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) |
88,321 European ancestry individuals |
A |
0.353893 |
8E-196 |
195.097 |
rs7350789 |
0.147002 |
triglycerides to total lipids in large VLDL percentage (EFO:0022332)
|
PMID:36764567 |
GWAS750657_H |
GCST90299542 |
Metabolite levels (1-arachidonoylglycerophosphoethanolamine; 1-arachidonoyl-GPE (20:4n6); C20:4 LPE; C20_4_LPE) |
11,272 European, Hispanic or African American individuals |
A |
0.3399 |
2E-27 |
26.699 |
rs7350789 |
0.154 |
1-arachidonoyl-GPE (20:4n6) measurement (EFO:0800248)
|
PMID:37253714 |
GWAS751008_H |
GCST90299688 |
Metabolite levels (1-linoleoylglycerophosphoethanolamine; 1-linoleoyl-GPE (18:2); C18:2 LPE; C18_2_LPE) |
11,268 European, Hispanic or African American individuals |
A |
0.3399 |
5E-18 |
17.302 |
rs7350789 |
0.123 |
1-linoleoyl-GPE (18:2) measurement (EFO:0800247)
|
PMID:37253714 |
None Available |
GCST90091604 |
Fasting sphingomyelins |
null |
A |
0.355478417 |
2E-12 |
11.699 |
rs7350789 |
0.150708 |
sphingomyelin measurement (EFO:0010118)
|
PMID:34610981 |
None Available |
GCST90091669 |
Postprandial free cholesterol in IDL |
null |
A |
0.357569489 |
9E-11 |
10.046 |
rs7350789 |
0.143914 |
free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595)
|
PMID:34610981 |